Skip to content
logo
  • Home
  • About
    • About GSAM
    • Our Team
    • PEACE
  • Resources
    • About Addiction
    • GSAM NEWS
    • Links
    • Conference
  • GSAM NEWS
  • Contacts
  • Members
    • GSAM 2025-2027 Call for Vote
    • Become A Member
    • Login
    • My GSAM Account
    • Members Roster
    • Member Events
    • Chapter Meetings Minutes & Agendas
    • Member’s Only Discussions
    • Chapter Documents
      • ASAM Chapter Affiliation Agreement
      • ASAM Chapter Agreement
      • Constitution and Bylaws
    • Member Resources
      • Practice Management Resources
      • Report Pharmacy Access Issues

Annual Conference

Nominations

No products in the cart.

logo
  • Home
  • About
    • About GSAM
    • Our Team
    • PEACE
  • Resources
    • About Addiction
    • GSAM NEWS
    • Links
    • Conference
  • GSAM NEWS
  • Contacts
  • Members
    • GSAM 2025-2027 Call for Vote
    • Become A Member
    • Login
    • My GSAM Account
    • Members Roster
    • Member Events
    • Chapter Meetings Minutes & Agendas
    • Member’s Only Discussions
    • Chapter Documents
      • ASAM Chapter Affiliation Agreement
      • ASAM Chapter Agreement
      • Constitution and Bylaws
    • Member Resources
      • Practice Management Resources
      • Report Pharmacy Access Issues

Annual Conference

Nominations

No products in the cart.

  • Home
  • About
    • About GSAM
    • Our Team
    • PEACE
  • Resources
    • About Addiction
    • GSAM NEWS
    • Links
    • Conference
  • GSAM NEWS
  • Contacts
  • Members
    • GSAM 2025-2027 Call for Vote
    • Become A Member
    • Login
    • My GSAM Account
    • Members Roster
    • Member Events
    • Chapter Meetings Minutes & Agendas
    • Member’s Only Discussions
    • Chapter Documents
      • ASAM Chapter Affiliation Agreement
      • ASAM Chapter Agreement
      • Constitution and Bylaws
    • Member Resources
      • Practice Management Resources
      • Report Pharmacy Access Issues
Addiction Medicine Updates Articles of Interest Legislation White Papers
0
0
December 15, 2022

ASAM’s Public Policy Statement on Regulation of Opioid Use Disorder Treatment

Public Policy Statement on the Regulation of the Treatment of Opioid Use Disorder with Methadone 

Excerpt:

The treatment of opioid use disorder (OUD) with methadone has a long history and robust scientific evidence supporting its effectiveness. Currently, U.S. federal law limits its availability to certified, accredited, and heavily regulated opioid treatment programs (OTPs), a structure that has implications for access to, and quality of, care. This policy statement outlines existing regulatory barriers that prevent broader access to methadone treatment for OUD and summarizes current challenges to optimizing the quality of care offered by OTPs. Recommendations address ways to improve both access to, and the quality of, methadone treatment for OUD by making such treatment more patient-centered and integrated with other medical care. Such improvements are expected to reduce overdose deaths and improve health outcomes. 

View Full Article
Georgia Society of Addiction Medicine
Author: Georgia Society of Addiction Medicine

ASAM/GSAM Chapter Engagement Manager

Share

Post navigation

Prev
Next

Leave a Comment Cancel reply

Your email address will not be published. Required fields are marked *

The Georgia Society of Addiction Medicine 

Social Media

Recent Posts

  • Georgians for Responsible Marijuana Policy: Important Marijuana Study Committee Hearing Tomorrow October 24, 2025
  • The Joint Clinical Practice Guideline on Benzodiazepine (BZD) Tapering October 15, 2025

Quick News

Another Brilliant Design by: Adwebvertising…It’s Like Advertising…Only Better!

Copyright © 2022, Georgia Society of Addiction Medicine. All Rights Reserved